To account for the heterogeneity of cancer cells and CAFs, we conducted single-cell RNA sequencing with CD45-negative enriched cells from surgical samples of 17 pancreatic tumor patients (16 pancreatic cancer and one HGD with IPMN pathology) (Fig. 1A). This evidence concerns the gene PTPRC and pancreatic neoplasm.